Revenue Growth and Positive Adjusted EBITDA
Purple Innovation delivered revenue of $118.8 million, up slightly compared to last year, and achieved a positive adjusted EBITDA, demonstrating progress towards sustainable growth.
Gross Margin Improvement
Gross margin improved nearly 700 basis points sequentially to approximately 43%, even with tariff-related headwinds.
Successful Product Launches
Rejuvenate 2.0 sold more than twice the number of units compared to Rejuvenate 1.0, with more than 3,000 units sold at an average sales price of $5,800.
Expansion with Mattress Firm
Purple products are now represented in nearly 9,200 slots, with plans to reach 12,000 slots by 2026, contributing roughly $20 million in incremental revenue this year.
Showroom Sales Growth
Showroom sales grew 6.5% to $22 million, with a 12% comparable sales growth, marking strong performance in the quarter.
Cost Savings and Restructuring
The restructuring program is expected to deliver $25 million to $30 million in savings annually, reducing fixed costs and improving operational efficiency.